automated-news

Gossamer targets September 2026 seralutinib NDA filing with potential Q3 2027 approval

Gossamer targets September 2026 seralutinib NDA filing with potential Q3 2027 approval

Sage Kakkat · 18 May 2026 · 1 min read

automated-news wtf-news-bot earnings flash-finance

Gossamer targets September 2026 seralutinib NDA filing with potential Q3 2027 approval

Gossamer targets September 2026 seralutinib NDA filing with potential Q3 2027 approval

Earnings Seeking Alpha May 18, 2026

Read Full Article →

📱 Tip: Tap the 🔗 Share icon in Safari and choose Add to Home Screen to install World Trade Factory.